Drawing for KIDO2 ' S

USPTO serial 76176325

KIDO2 ' S

Reviewed by CopyMark Law Group

Reg. 2555475Status 710
Filing date
Status date
Registration date
Apr 2, 2002
Examiner
FERRANTE, NICHOLAS
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with KIDO2 ' S?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph R. Dreitler

Joseph R. Dreitler DREITLER TRUE LLC137 E. State StreetCOLUMBUS, OH 43215UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010medical devices for use in the delivery of aerosol and/or oxygen consisting of a regulator and a nebulizerSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 9, 2012CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jan 22, 2012TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 13, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 30, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 14, 2007CFITCASE FILE IN TICRS—
Aug 31, 2006COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Aug 29, 2006FAXXFAX RECEIVED—
Aug 21, 2006ALIEASSIGNED TO LIE—
May 4, 2006RRPRRESPONSE RECEIVED TO POST REG. ACTION—
May 4, 2006MAILPAPER RECEIVED—
Dec 30, 2005PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Oct 28, 2005PLGLASSIGNED TO PARALEGAL—
Sep 2, 2005MAILPAPER RECEIVED—
Apr 21, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 2, 2002R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 8, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 19, 2001NPUBNOTICE OF PUBLICATION—
Aug 31, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 31, 2001ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jul 24, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 16, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 18, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 21, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance